NeuroXess Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $103M

  • Investors
  • 22

NeuroXess General Information

Description

Manufacturer of a brain-computer interface technology designed for neurological research and medical applications. The company's technology utilizes flexible polyimide electrodes, wireless power modules, machine learning algorithms, high-density neural sensors, and cloud-based decoding platforms, providing healthcare institutions with a fully implantable system to restore motor and speech functions in patients with neurological impairments.

Contact Information

Website
www.neuroxess.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1907, Block A, Bohui Plaza
  • Number 325 Longhua East Road, Huangpu District
  • Shanghai, 201107
  • China
+86 400
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Vertical(s)
Advanced Manufacturing, Manufacturing, Life Sciences
Corporate Office
  • Room 1907, Block A, Bohui Plaza
  • Number 325 Longhua East Road, Huangpu District
  • Shanghai, 201107
  • China
+86 400

NeuroXess Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroXess Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 03-Jul-2026 $103M Completed Generating Revenue
3. Early Stage VC 14-Jan-2026 Completed Generating Revenue
2. Early Stage VC (Series A) 27-Dec-2022 $15.2M Completed Generating Revenue
1. Seed Round 24-Dec-2021 $15.2M $15.2M Completed Startup
To view NeuroXess’s complete valuation and funding history, request access »

NeuroXess Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroXess Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Fortune-Tech Capital Venture Capital Minority
Co-Stone Capital PE/Buyout Minority
Huafu Securities Asset Manager Minority
IDG Capital Venture Capital Minority
Jiangxi Financial Holding Group Government Minority
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial

NeuroXess FAQs

  • When was NeuroXess founded?

    NeuroXess was founded in 2021.

  • Where is NeuroXess headquartered?

    NeuroXess is headquartered in Shanghai, China.

  • What is the size of NeuroXess?

    NeuroXess has 70 total employees.

  • What industry is NeuroXess in?

    NeuroXess’s primary industry is Therapeutic Devices.

  • Is NeuroXess a private or public company?

    NeuroXess is a Private company.

  • What is NeuroXess’s current revenue?

    The current revenue for NeuroXess is .

  • How much funding has NeuroXess raised over time?

    NeuroXess has raised $118M.

  • Who are NeuroXess’s investors?

    China Fortune-Tech Capital, Co-Stone Capital, Huafu Securities, IDG Capital, and Jiangxi Financial Holding Group are 5 of 22 investors who have invested in NeuroXess.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process